Elevance Retained Earnings from 2010 to 2024

ELV Stock

USD 403.60 6.12 1.54%

Elevance Health Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that Elevance Health retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2000-12-31

Previous Quarter

34.6 B

Current Value

35.2 B

Quarterly Volatility

9.9 B

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Elevance Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevance Health's main balance sheet or income statement drivers, such as Interest Expense of 1.1 B, Total Revenue of 179.9 B or Gross Profit of 56 B, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0153 or PTB Ratio of 1.5. Elevance financial statements analysis is a perfect complement when working with Elevance Health Valuation or Volatility modules.

Check out the analysis of Elevance Health Correlation against competitors.

For more information on how to buy Elevance Stock please use our How to Invest in Elevance Health guide.

Latest Elevance Health's Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Elevance Health over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Elevance Health's Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevance Health's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 31.75 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Elevance Retained Earnings Regression Statistics

	Arithmetic Mean	19,431,243,333
	Geometric Mean	16,654,224,845
	Coefficient Of Variation	44.57
	Mean Deviation	6,965,566,222
	Median	18,054,400,000
	Standard Deviation	8,659,594,249
	Sample Variance	74988572.6T
	Range	31.5B
	R-Value	0.98
	Mean Square Error	3928429.2T
	R-Squared	0.95
	Slope	1,888,660,179
	Total Sum of Squares	1049840015.8T

Elevance Retained Earnings History

	2024	33.3 B
	2023	31.7 B
	2022	29.7 B
	2021	27.1 B
	2020	23.8 B
	2019	22.6 B
	2018	20 B

Other Fundumenentals of Elevance Health

Retained Earnings Total Equity

Elevance Health Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Intangible Assets	Property Plant Equipment	Net Receivables	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Good Will	Deferred Long Term Liab	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Capital Stock
Total Assets		0.99	0.93	0.84	0.81	0.58	0.98	0.98	0.9	0.76	0.78	0.75	0.6	0.09	0.77	0.98	0.43	0.2	0.94	-0.7	0.59	0.0	0.67	0.68	-0.58
Total Stockholder Equity	0.99		0.92	0.84	0.8	0.59	0.96	0.97	0.94	0.74	0.78	0.71	0.61	0.23	0.82	0.98	0.44	0.15	0.91	-0.69	0.53	-0.04	0.61	0.63	-0.52
Net Debt	0.93	0.92		0.73	0.68	0.56	0.97	0.87	0.89	0.6	0.84	0.62	0.64	0.19	0.74	0.95	0.59	0.01	0.82	-0.7	0.39	0.13	0.42	0.45	-0.38
Total Liab	0.84	0.84	0.73		0.98	0.8	0.82	0.81	0.81	0.96	0.66	0.95	0.49	0.04	0.84	0.87	0.43	0.33	0.9	-0.85	0.82	0.02	0.69	0.83	-0.77
Retained Earnings	0.81	0.8	0.68	0.98		0.79	0.78	0.77	0.73	0.99	0.65	0.96	0.52	-0.04	0.76	0.82	0.32	0.47	0.91	-0.82	0.85	-0.02	0.73	0.88	-0.8
Accounts Payable	0.58	0.59	0.56	0.8	0.79		0.6	0.56	0.57	0.79	0.5	0.79	0.29	0.03	0.7	0.64	0.47	0.33	0.67	-0.79	0.62	0.05	0.43	0.64	-0.56
Long Term Debt	0.98	0.96	0.97	0.82	0.78	0.6		0.93	0.89	0.72	0.82	0.74	0.6	0.1	0.76	0.98	0.53	0.16	0.9	-0.73	0.51	0.08	0.59	0.59	-0.5
Short Term Investments	0.98	0.97	0.87	0.81	0.77	0.56	0.93		0.89	0.73	0.68	0.7	0.5	0.08	0.77	0.94	0.4	0.17	0.93	-0.63	0.59	-0.03	0.7	0.69	-0.6
Intangible Assets	0.9	0.94	0.89	0.81	0.73	0.57	0.89	0.89		0.65	0.71	0.63	0.51	0.43	0.91	0.95	0.58	-0.13	0.79	-0.7	0.44	0.04	0.41	0.47	-0.41
Property Plant Equipment	0.76	0.74	0.6	0.96	0.99	0.79	0.72	0.73	0.65		0.56	0.97	0.43	-0.13	0.71	0.76	0.28	0.53	0.88	-0.76	0.89	-0.03	0.78	0.93	-0.84
Net Receivables	0.78	0.78	0.84	0.66	0.65	0.5	0.82	0.68	0.71	0.56		0.59	0.79	0.18	0.65	0.81	0.42	0.09	0.71	-0.76	0.33	0.16	0.36	0.38	-0.3
Total Current Assets	0.75	0.71	0.62	0.95	0.96	0.79	0.74	0.7	0.63	0.97	0.59		0.39	-0.19	0.69	0.75	0.42	0.51	0.85	-0.79	0.86	0.0	0.76	0.89	-0.82
Short Term Debt	0.6	0.61	0.64	0.49	0.52	0.29	0.6	0.5	0.51	0.43	0.79	0.39		0.09	0.35	0.6	0.01	0.15	0.6	-0.48	0.34	-0.2	0.24	0.34	-0.31
Common Stock	0.09	0.23	0.19	0.04	-0.04	0.03	0.1	0.08	0.43	-0.13	0.18	-0.19	0.09		0.48	0.21	0.22	-0.56	-0.08	-0.13	-0.44	0.0	-0.39	-0.4	0.5
Current Deferred Revenue	0.77	0.82	0.74	0.84	0.76	0.7	0.76	0.77	0.91	0.71	0.65	0.69	0.35	0.48		0.84	0.57	-0.11	0.72	-0.82	0.46	0.17	0.4	0.48	-0.41
Good Will	0.98	0.98	0.95	0.87	0.82	0.64	0.98	0.94	0.95	0.76	0.81	0.75	0.6	0.21	0.84		0.54	0.11	0.91	-0.76	0.54	0.04	0.56	0.61	-0.52
Deferred Long Term Liab	0.43	0.44	0.59	0.43	0.32	0.47	0.53	0.4	0.58	0.28	0.42	0.42	0.01	0.22	0.57	0.54		-0.14	0.26	-0.41	0.14	0.13	0.05	0.11	-0.12
Net Tangible Assets	0.2	0.15	0.01	0.33	0.47	0.33	0.16	0.17	-0.13	0.53	0.09	0.51	0.15	-0.56	-0.11	0.11	-0.14		0.35	-0.11	0.52	-0.33	0.57	0.64	-0.49
Long Term Debt Total	0.94	0.91	0.82	0.9	0.91	0.67	0.9	0.93	0.79	0.88	0.71	0.85	0.6	-0.08	0.72	0.91	0.26	0.35		-0.74	0.76	0.0	0.8	0.84	-0.75
Capital Surpluse	-0.7	-0.69	-0.7	-0.85	-0.82	-0.79	-0.73	-0.63	-0.7	-0.76	-0.76	-0.79	-0.48	-0.13	-0.82	-0.76	-0.41	-0.11	-0.74		-0.56	-0.35	-0.42	-0.54	0.5
Long Term Investments	0.59	0.53	0.39	0.82	0.85	0.62	0.51	0.59	0.44	0.89	0.33	0.86	0.34	-0.44	0.46	0.54	0.14	0.52	0.76	-0.56		-0.06	0.76	0.95	-0.99
Short Long Term Debt	0.0	-0.04	0.13	0.02	-0.02	0.05	0.08	-0.03	0.04	-0.03	0.16	0.0	-0.2	0.0	0.17	0.04	0.13	-0.33	0.0	-0.35	-0.06		-0.11	-0.11	0.07
Cash And Equivalents	0.67	0.61	0.42	0.69	0.73	0.43	0.59	0.7	0.41	0.78	0.36	0.76	0.24	-0.39	0.4	0.56	0.05	0.57	0.8	-0.42	0.76	-0.11		0.89	-0.79
Net Invested Capital	0.68	0.63	0.45	0.83	0.88	0.64	0.59	0.69	0.47	0.93	0.38	0.89	0.34	-0.4	0.48	0.61	0.11	0.64	0.84	-0.54	0.95	-0.11	0.89		-0.95
Capital Stock	-0.58	-0.52	-0.38	-0.77	-0.8	-0.56	-0.5	-0.6	-0.41	-0.84	-0.3	-0.82	-0.31	0.5	-0.41	-0.52	-0.12	-0.49	-0.75	0.5	-0.99	0.07	-0.79	-0.95

Click cells to compare fundamentals

About Elevance Health Financial Statements

Elevance Health investors use historical fundamental indicators, such as Elevance Health's Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevance Health. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	31.7 B	33.3 B
Retained Earnings Total Equity	34.2 B	17.6 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elevance Stock Analysis

When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC